EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Current knowledge of small cell lung cancer transformation from non-small cell lung cancer

Giuseppe Giaccone, Yongfeng He

Seminars in Cancer Biology · 2023-09 · 94 · 1-10

DOI: 10.1016/j.semcancer.2023.05.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2023-09. Verfasst von Giuseppe Giaccone und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sandra and Edward Meyer Cancer Center, Weill-Cornell Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 117 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is the leading cause of cancer related death, and is divided into two major histological subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Histological transformation from NSCLC to SCLC has been reported as a mechanism of treatment resistance in patients who received tyrosine kinase inhibitors (TKIs) targeting EGFR, ALK and ROS1 or immunotherapies. The transformed histology could be due to therapy-induced lineage plasticity or clonal selection of pre-existing SCLC cells. Evidence supporting either mechanism exist in the literature. Here, we discuss potential mechanisms of transformation and review the current knowledge about cell of origin of NSCLC and SCLC. In addition, we summarize genomic alterations that are frequently observed in both "de novo" and transformed SCLC, such as TP53, RB1 and PIK3CA. We also discuss treatment options for transformed SCLC, including chemotherapy, radiotherapy, TKIs, immunotherapy and anti-angiogenic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsSmall Cell Lung CarcinomaHumansProtein-Tyrosine KinasesErbB ReceptorsProtein Kinase InhibitorsProto-Oncogene ProteinsMutation

Stichwörter der Autor:innen

HeterogeneityLineage plasticityNSCLCSCLCTransformation

Substanzen

Protein-Tyrosine KinasesErbB ReceptorsProtein Kinase InhibitorsProto-Oncogene Proteins

Autor:innen und Institutionen

  • Sandra and Edward Meyer Cancer Center, Weill-Cornell Medicine, New York, NY, USA.
  • Sandra and Edward Meyer Cancer Center, Weill-Cornell Medicine, New York, NY, USA. Electronic address: yoh4003@med.cornell.edu.

Zitieren

APA

Giaccone, G., & He, Y. (2023). Current knowledge of small cell lung cancer transformation from non-small cell lung cancer. Seminars in Cancer Biology, 94, 1-10. https://doi.org/10.1016/j.semcancer.2023.05.006

Vancouver

Giaccone G, He Y. Current knowledge of small cell lung cancer transformation from non-small cell lung cancer. Seminars in Cancer Biology. 2023;94:1-10. doi:10.1016/j.semcancer.2023.05.006

BibTeX
@article{Giaccone2023,
  author = {Giaccone, Giuseppe and He, Yongfeng},
  title = {Current knowledge of small cell lung cancer transformation from non-small cell lung cancer},
  journal = {Seminars in Cancer Biology},
  year = {2023},
  volume = {94},
  pages = {1--10},
  doi = {10.1016/j.semcancer.2023.05.006}
}
Kostenlos starten →